AGP Picks
View all

Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on September 8, 2026

Euro Sun Mining Announces Non‑Binding MoU for US$400 Million Senior Debt Facility and Term Sheet for US$3 Million Strategic Equity Investment
GE Aerospace to Acquire Consolidated Precision Products (CPP), Expanding Mission-Critical Castings Capacity
United Community Banks, Inc. Announces Completion of Strategic Initiatives That Simplify and Strengthen Balance Sheet; Increased Share Repurchase Authorization
Edible Garden to Participate in ECRM’s Vitamin, Weight Management & Sports Nutrition Session, September 14–17, 2026
ASML begins construction of new Eindhoven campus, strengthening its presence in the Brainport region
Transaction in Own Shares
Polar Power Reduces Pinnacle Bank Debt by $3 Million, from Approximately $4.7 Million to $1.667 Million; Expects Remaining Balance to Be Paid Down by End of September
A Single Filing Reveals Elon Musk's Plan to Make Artificial Intelligence a "Winner Take All" Game, Says Top AI Expert James Altucher
Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors
SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES NAME CHANGE TO IMPAUER TECHNOLOGIES INC. AND NEW TRADING SYMBOLS
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
Generate Biomedicines Inc. to Participate in September Investor Conferences
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Lantronix CEO to Participate in Upcoming Investor and Industry Events
IREN’s 2GW Sweetwater Hub Included as Base Load in ERCOT Batch Zero
Invivyd to Participate in Upcoming September Investor Conferences
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Business Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.